News | February 23, 2022
GSK introduces Haleon to the world
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
US $ 555,000 invested by Wavemaker Partners in pre-seed round
9T Labs provides a cost-competitive solution for manufacturing that will allow structural CFRP parts to replace metals at a much faster rate in demanding applications in many sectors such as aerospace, automotive and healthcare
Ligand expects 2022 royalties of $55 million to $60 million, material sales of $40 million to $50 million, and contract revenue of $52 million to $62 million.
Funding will support continued advancement of Centauri’s antimicrobial resistance research to identify novel therapeutic candidates using its proprietary Alphamer platform
Funding to grow the insurance and digital therapeutics vertical in India
The funds will be used to expand digital product offerings, grow their online customer base, and launch their flagship clinic in Bengaluru
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
Dr. Reddy’s included in S&P Global’s Sustainability Yearbook for the 2nd year and Bloomberg Gender-Equality Index for the 5th year in a row
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
Subscribe To Our Newsletter & Stay Updated
